{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-202204","form_type":"8-K","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2024-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.452460+00:00","generated_at":"2026-05-31T08:56:00.574917+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ResMed appoints Christopher DelOrefice to board of directors, effective August 15, 2024","bullets":["DelOrefice is EVP and CFO of Becton Dickinson, brings 30+ years of audit, finance and strategic expertise.","Board expanded to 11 members; DelOrefice will serve on audit committee.","Appointment effective immediately; will stand for re-election at Nov 21, 2024 annual meeting.","DelOrefice previously served as VP Investor Relations at Johnson & Johnson and CFO of North America Hospital Medical Devices."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-202204","json":"https://secwatch.observer/filing/0001193125-24-202204.json","markdown":"https://secwatch.observer/filing/0001193125-24-202204.md","text":"https://secwatch.observer/filing/0001193125-24-202204.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312524202204/0001193125-24-202204-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312524202204/d885393d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:56:00.574917+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8473931ca3","claim":"Christopher DelOrefice was appointed as Director at RESMED INC.","evidence_excerpt":"On August 15, 2024, ResMed Inc. appointed Christopher DelOrefice to serve on its board of directors, with a term expiring at ResMed’s 2024 annual meeting of stockholders on November 21, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/943819/000119312524202204/0001193125-24-202204-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}